当前我国基孔肯雅热防控的挑战和应对措施

doi:10.19871/j.cnki.xfcrbzz.2025.04.001

摘要/Abstract

摘要： 基孔肯雅热（chikungunya fever, CHIKF）是由基孔肯雅病毒（chikungunya virus, CHIKV）感染引起的传染性疾病,主要通过埃及伊蚊和白纹伊蚊传播。近年来,随着全球气候变暖及国际旅行日益频繁,CHIKV的传播范围不断扩大,已成为全球公共卫生安全的重要威胁。CHIKF患者常表现为发热、关节痛和皮疹,部分患者可发展为慢性关节炎,严重影响生活质量。目前,尚无针对CHIKF的特效抗病毒药物,疫苗接种尚未广泛覆盖,疫情监测和蚊媒防控是遏制CHIKF传播的关键。本文综述了CHIKF的病原学特征、流行现状、临床表现及诊断方法,分析了当前防控工作的难点,并提出了多学科融合、科技赋能和社会动员的综合防控策略,为我国应对CHIKF及其他蚊媒传播疾病提供借鉴。

关键词: 基孔肯雅热, 基孔肯雅病毒, 蚊媒传播疾病, 气候变化, 蚊媒控制

Abstract: Chikungunya fever (CHIKF) is a mosquito-borne infectious disease caused by the chikungunya virus (CHIKV), primarily transmitted through Aedes aegypti and Aedes albopictus mosquitoes. In recent years, with global climate warming and the expansion of international travel, the endemic range of CHIKV has continued to expand, making it a significant global public health threat. Infected individuals typically present with fever, arthralgia, and rash, and some patients developing chronic arthritis that severely affects quality of life. Currently, there are no specific antiviral treatments for CHIKF, and vaccines have not yet achieved widespread coverage, making epidemic surveillance and vector control crucial for curbing disease transmission. This article reviews the virological characteristics, epidemiological status, clinical manifestations, and diagnostic methods of CHIKV, analyzes current challenges in prevention and control efforts, and proposes comprehensive strategies integrating multidisciplinary collaboration, technological empowerment, and social mobilization, providing insights for China's response to CHIKF and other mosquito-borne diseases.

Key words: Chikungunya fever, Chikungunya virus, Mosquito-borne diseases, Climate change, Mosquito control

中图分类号:

R511

徐旭雯, 蔡少航, 莫希超, 夏牧晔, 徐钰源, 彭劼. 当前我国基孔肯雅热防控的挑战和应对措施[J]. 新发传染病电子杂志, 2025, 10(4): 1-6.

Xu Xuwen, Cai Shaohang, Mo Xichao, Xia Muye, Xu Yuyuan, Peng Jie. Epidemiological challenges and public health strategies for chikungunya fever prevention and control in China[J]. Electronic Journal of Emerging Infectious Diseases, 2025, 10(4): 1-6.

参考文献

[1] PÉREZ-ESTIGARRIBIA PE, RIBEIRO DOS SANTOS G, CAUCHEMEZ S, et al. Modeling the impact of vaccine campaigns on the epidemic transmission dynamics of chikungunya virus outbreaks[J]. Nat Med, 2025, 31(7): 2335-2341.
[2] DE SOUZA WM, DE LIMA STS, SIMÕES MELLO LM, et al. Spatiotemporal dynamics and recurrence of chikungunya virus in Brazil: an epidemiological study[J]. Lancet Microbe, 2023, 4(5): e319-e329.
[3] 广东省疾病预防控制中心. 佛山通报基孔肯雅热疫情防控最新情况[EB/OL].[2025-07-20]. https://cdcp.gd.gov.cn/ywdt/zdzt/yfjkkyr/yqxx/content/post_4747607.html.
[4] 广东省疾病预防控制中心. 广东省基孔肯雅热监测信息[EB/OL].[2025-08-03]. https://cdcp.gd.gov.cn/ywdt/zdzt/yfjkkyr/yqxx/content/post_4754034.html.
[5] PHADUNGSOMBAT J, IMAD HA, NAKAYAMA EE, et al.Spread of a novel Indian Ocean lineage carrying E1-K211E/E2-V264A of chikungunya virus East/Central/South African genotype across the Indian subcontinent, Southeast Asia, and eastern Africa[J]. Microorganisms, 2022, 10(2): 354.
[6] WEAVER SC, CHEN R, DIALLO M.Chikungunya virus: role of vectors in emergence from enzootic cycles[J]. Annu Rev Entomol, 2020, 65(1): 313-332.
[7] WHO. Chikungunya epidemiology update-June 2025[EB/OL]. [2025-06-11]. https://www.who.int/publications/m/item/chikungunya-epidemiology-update-june-2025
[8] RIBEIRO DOS SANTOS G, JAWED F, MUKANDAVIRE C, et al. The global burden of chikungunya virus and the potential benefit of vaccines[J]. Nat Med. 2025, 31(7): 2342-2349.
[9] NYAMWAYA DK, OTIENDE M, MWANGO L, et al.Incidence of chikungunya virus infections among Kenyan children with neurological disease, 2014-2018: a cohort study[J]. PLOS Med, 2022, 19(5): e1003994.
[10] DE SOUZA WM, DE LIMA STS, SIMÕES MELLO LM, et al. Spatiotemporal dynamics and recurrence of chikungunya virus in Brazil: an epidemiological study[J]. Lancet Microbe, 2023, 4(5): e319-e329.
[11] MEHAND MS, Al-SHORBAJI F, MILLETT P, et al.The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts[J]. Antiviral Res, 2018, 159: 63-67.
[12] 陈斌, 陈秋兰, 李昱, 等. 2010—2019 年中国输入性基孔肯雅热病例流行病学特征分析[J]. 疾病监测, 2021, 36(6): 539-543.
[13] YANG CF, SU CL, HSU TC, et al.Imported chikungunya virus strains, Taiwan, 2006-2014[J]. Emerg Infect Dis, 2016, 22(11): 1981-1984.
[14] WU D, WU J, ZHANG Q, et al.Chikungunya outbreak in Guangdong Province, China, 2010[J]. Emerg Infect Dis, 2012, 18(3): 493-495.
[15] SIMON F, SAVINI H, PAROLA P.Chikungunya: a paradigm of emergence and globalization of vector-borne diseases[J]. Med Clin North Am, 2008, 92(6): 1323-1343.
[16] LEAO JC, MARQUES CDI, DUARTE A, et al.Chikungunya fever: general and oral healthcare implications[J]. Oral Dis, 2018, 24(1-2): 233-237.
[17] GIANCOTTI G, CANCELLIERI M, BALBONI A, et al.Rational modifications on a benzylidene-acrylohydrazide antiviral scaffold, synthesis and evaluation of bioactivity against chikungunya virus[J]. Eur J Med Chem, 2018, 149: 56-68.
[18] BARTHOLOMEEUSEN K, DANIEL M, LABEAUD DA, et al.Chikungunya fever[J]. Nat Rev Dis Primers, 2023, 9(1): 17.
[19] SANTIAGO RA, BAVARESCO SPP, CITRANGULO SG.Clinical manifestations associated with the chronic phase of Chikungunya Fever: A systematic review of prevalence[J]. PLoS Negl Trop Dis, 2025, 19(2): e0012810.
[20] BURT F, CHEN W, MAHALINGM S.Chikungunya virus and arthritic disease[J]. Lancet Infect Dis, 2014, 14(9): 789-790.
[21] LO PRESTI A, CELLA E, ANGELETTI S, et al.Molecular epidemiology, evolution and phylogeny of chikungunya virus: an updating review[J]. Infect Genet Evol, 2016, 41: 270-278.
[22] PORTO SILVA CN, CRISPIM JG, PEREIRA MC, et al.The communication between chikungunya infection and the central nervous system[J]. Microb Pathog, 2025, 206: 107747.
[23] BRITO FERREIRA ML, MILITÃO DE ALBUQUERQUE MDFP, DE BRITO CAA, et al. Neurological disease in adults with Zika and chikungunya virus infection in Northeast Brazil: a prospective observational study[J]. Lancet Neurol, 2020, 19(10): 826-839.
[24] NYAMWAYA DK, OTIENDE M, MWANGO L, et al.Incidence of chikungunya virus infections among Kenyan children with neurological disease, 2014-2018: a cohort study[J]. PLOS Med, 2022, 19(5): e1003994.
[25] PAN AMERICAN HEALTH ORGANIZATION. Guidelines for the Clinical Diagnosis and Treatment of Dengue, Chikungunya,Zika (Pan American Health Organization, 2022)[EB/OL]. [2022]. https://iris.paho.org/handle/10665.2/55867
[26] WHO. Chikungunya fact sheet[EB/OL]. [2016-05-08].http://www.who.int/mediacentre/factsheets/fs327/en/(2016.
[27] 国家卫生健康委办公厅,国家中医药局综合司.《基孔肯雅热诊疗方案》2025年版[EB/OL].[2025-07-31].https://www.nhc.gov.cn/ylyjs/gzdt/202507/c592a4f82dd7405e9be5302e4147c0c7.shtml.
[28] WEBB E, MICHELEN M, RIGBY I, et al.An evaluation of global chikungunya clinical management guidelines: a systematic review[J]. E Clinical Medicine, 2022, 54: 101672.
[29] FERNANDES AIV, SOUZA JR, SILVA AR, et al.Immunoglobulin therapy in a patient with severe chikungunya fever and vesiculobullous lesions[J]. Front Immunol, 2019, 10: 1498.
[30] 中国疾病预防控制中心. 基孔肯雅热防控技术指南(2025年版)[EB/OL]. (2025-07-30)[2025-08-05]. https://www.chinacdc.cn/jkyj/crb2/qt/jkkyr/jswj_jkkyr/.
[31] ARANLALLE VA, SHRIVASTAVA S, CHERIAN S, et al.Genetic divergence of chikungunya viruses in India (1963-2006) with special reference to the 2005-2006 explosive epidemic[J]. J Gen Virol, 2007, 88(Pt 7): 1967-1976.
[32] DELISLE E, ROUSSEAU C, BROCHE B, et al.Chikungunya outbreak in Montpellier, France, September to October 2014[J]. Euro Surveill, 2015, 20(17): 21108.
[33] ANGELINI P, MACIBI P, FINARELLI AC, et al.Chikungunya epidemic outbreak in Emilia-Romagna (Italy) during summer 2007[J]. Parassitologia, 2008, 50(1-2):97-98.
[34] TSETSARKIN KA, CHEN R, WEAVER SC.Interspecies transmission and chikungunya virus emergence[J]. Curr Opin Virol, 2016, 16: 143-150.
[35] TSETSARKIN KA, CHEN R, LEAL G, et al.Chikungunya virus emergence is constrained in Asia by lineage-specific adaptive landscapes[J]. Proc Natl Acad Sci U S A, 2011, 108(19) : 7872-7827.
[36] TSETSARKIN KA, WEAVER SC.Sequential adaptive mutations enhance efficient vector switching by chikungunya virus and its epidemic emergence[J]. PLoS Pathog, 2011, 7(12): e1002412.
[37] TSETSARKIN KA, MCGEE CE, VOLK SM, et al.Epistatic roles of E2 glycoprotein mutations in adaption of chikungunya virus to Aedes albopictus and Ae. aegypti mosquitoes[J]. PLoS One. 2009, 4(8): e6835.
[38] TSETSARKIN KA, VANLANDINGHAM DL, MCGEE CE, et al.A single mutation in chikungunya virus affects vector specificity and epidemic potential[J]. PLoS Pathog, 2007, 3(12): e201.
[39] SCHUFFENEECKER I, ITEMAN I, MICHAULT A, et al.Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak[J]. PLoS Med, 2006, 3(7): e263.
[40] DE SOUZA WM, WEAVER SC.Effects of climate change and human activities on vector-borne diseases[J]. Nat Rev Microbiol, 2024, 22(8): 476-491.
[41] CHOWELL G, MIZUMOTO K, BANDA JM, et al.Assessing the potential impact of vector-borne disease transmission following heavy rainfall events: a mathematical framework[J]. Philos Trans R Soc B Biol Sci, 2019, 374(1775): 20180272.
[42] ALVARADO-CASTRO V, PAREDES-SOLIS S, NAVA-AGUILERA E, et al.Assessing the effects of interventions for Aedes aegypti control: systematic review and meta-analysis of cluster randomised controlled trials[J]. BMC Public Health, 2017, 17(Suppl 1): 384.
[43] KASMAN K, ISHAK H, ALAM G, et al . Resistance status of Aedes mosquitoes as dengue vectors and the potential of plant larvicides from Indonesia for biological control: a narrative review[J]. Narra J, 2025, 5(1): e1819.
[44] 赵春春,朱彩英,贾清臣,等. 2017-2018年我国不同区域白纹伊蚊对常用杀虫剂的抗药性[J]. 中国媒介生物学及控制杂志,2020, 31(2): 126-132.